The Lancet Infectious Diseases
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Shifting transmission patterns of human mpox in South Kivu, DR Congo.
24:e354-e355.
2024
-
Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity.
24:e654-e658.
2024
-
The importance of getting the ethics right in a pandemic treaty.
23:e489-e496.
2023
-
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.
23:856-866.
2023
-
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019.
22:1626-1647.
2022
-
The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy.
22:1528-1530.
2022
-
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019.
22:222-241.
2022
-
The value of open-source clinical science in pandemic response: lessons from ISARIC.
21:1623-1624.
2021
-
Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
21:1429-1440.
2021
-
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach.
21:601-602.
2021
-
The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada.
21:593-594.
2021
-
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
21:e103-e109.
2021
-
Chlamydia pneumoniae mucositis syndrome.
20:1216-1216.
2020
-
Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study.
20:487-497.
2020
-
Curbing the 2019 Samoa measles outbreak.
20:287-288.
2020
-
Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017.
20:37-59.
2020
-
Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017.
20:60-79.
2020
-
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool.
19:1278-1280.
2019
-
The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017.
19:1312-1324.
2019
-
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis.
19:143-155.
2019
-
Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study.
18:1329-1349.
2018
-
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.
18:1211-1228.
2018
-
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study.
18:516-525.
2018
-
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.
18:95-107.
2018
-
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.
17:909-948.
2017
-
Evaluating Ebola vaccine trials: insights from simulation.
15:1134-1134.
2015
-
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis.
15:703-710.
2015
-
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
15:528-534.
2015
-
Yersinia pestis and the three plague pandemics–Authors' reply.
14:919-919.
2014
-
Mobile phone reminders for paediatric HIV follow-up care.
14:540-541.
2014
-
Yersinia pestis and the Plague of Justinian 541–543 AD: a genomic analysis.
14:319-326.
2014
-
Antibiotic resistance—the need for global solutions.
13:1057-1098.
2013
-
Adherence to antiretroviral therapy: supervision or support?.
12:97-98.
2012
-
HIV status in serodiscordant couples – Authors' reply.
11:659-659.
2011
-
HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis.
10:770-777.
2010
-
Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis.
10:464-469.
2010
-
Highlights from the 17th CROI.
10:221-221.
2010
-
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.
7:21-31.
2007
-
HIV infection as a weapon of war.
6:752-753.
2006
-
Barriers to participation in HIV drug trials: a systematic review.
6:32-38.
2006
-
The HIV/AIDS epidemic in Cambodia.
5:596-597.
2005
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)